Rohm (OTCMKTS:ROHCY – Get Free Report) is anticipated to issue its results after the market closes on Thursday, November 5th. Analysts expect the company to post earnings of $0.21 per share and revenue of $903.63 million for the quarter.
Rohm (OTCMKTS:ROHCY – Get Free Report) last issued its earnings results on Wednesday, August 5th. The technology company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.02). Rohm had a negative net margin of 29.85% and a positive return on equity of 4.39%. The firm had revenue of $851.76 million during the quarter, compared to analyst estimates of $813.37 million. On average, analysts expect Rohm to post $0.72 EPS for the current fiscal year and $1.21 EPS for the next fiscal year.
Rohm Stock Up 0.5%
ROHCY stock opened at $22.29 on Tuesday. The stock’s 50 day simple moving average is $28.96 and its 200 day simple moving average is $25.86. Rohm has a fifty-two week low of $12.62 and a fifty-two week high of $36.52. The company has a debt-to-equity ratio of 0.39, a quick ratio of 3.12 and a current ratio of 4.17. The company has a market cap of $8.60 billion, a P/E ratio of 41.17 and a beta of 1.36.
About Rohm
ROHM Co, Ltd. is a Japan-based semiconductor and electronic components manufacturer headquartered in Kyoto. The company develops and produces integrated circuits, discrete semiconductors and electronic components used in automotive, industrial equipment, consumer electronics, telecommunications and other applications.
Its product portfolio includes power management and analog ICs, microcontrollers, LEDs, diodes, transistors, resistors, sensors and timing devices. ROHM also focuses on power semiconductors made with silicon carbide (SiC) and other advanced materials, which are designed to support greater energy efficiency in electric vehicles, charging systems, renewable-energy equipment and industrial power supplies.
Founded in 1958 as Toyo Denpa Kogyo Co, Ltd., the company adopted the name ROHM Co, Ltd.
Featured Stories
- Five stocks we like better than Rohm
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Rohm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rohm and related companies with MarketBeat.com's FREE daily email newsletter.
